Orthopediatrics Corp: Piper Sandler raises target price to $45 from $30
KIDS•Piper Sandler raised its target price for Orthopediatrics Corp to $45 from $30.
Related News

Evotec, Bristol Myers Squibb secure second FDA IND clearance in protein degradation partnership
EVO•

Goldman Sachs increases total voting rights in Aixtron to 8.70% from 8.59%
GS•

KT Skylife to merge with wholly owned subsidiary KT HCN
KT•

AstraZeneca's sonesitatug vedotin gets FDA priority review for advanced gastric cancers
AZN•

Nasdaq trade halt continues; reason not available at 03:58 am
HCHL•